Legal & General Group
TELA icon

Legal & General Group’s TELA Bio TELA Stock Holding History

Legal & General Group’s Portfolio TELA Stock Details TELA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,937
Closed -$11K – 3506
2024
Q1 		$11K Hold
1,937
– – ﹤0.01% 3185
2023
Q4 		$12.8K Hold
1,937
– – ﹤0.01% 3189
2023
Q3 		$15.5K Hold
1,937
– – ﹤0.01% 3127
2023
Q2 		$19.6K Buy
+1,937
New +$19.8K ﹤0.01% 3119
2021
Q2 		– Sell
-837
Closed -$12K – 3642
2021
Q1 		$12K Hold
837
– – ﹤0.01% 3329
2020
Q4 		$13K Hold
837
– – ﹤0.01% 3255
2020
Q3 		$14K Sell
837
-56
-6% -$786 ﹤0.01% 3104
2020
Q2 		$12K Buy
+893
New +$11.7K ﹤0.01% 3270

Other funds holding TELA

EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Legal & General Group's TELA Position: Q2 2024 in Review

Legal & General Group sold out of TELA Bio (TELA) in Q2 2024, closing a stake of 1,937 shares — an estimated $11K sold.

Legal & General Group first reported a position in TELA in Q2 2020 and held it in 8 quarters. The position peaked at $19.6K in Q2 2023. 68 funds tracked by Wall St. Rank hold TELA as of Q2 2024.

  • Legal & General Group reported no remaining TELA Bio position as of Q2 2024 after selling out during the quarter.
  • Legal & General Group sold 1,937 TELA Bio shares in Q2 2024, an estimated $11K.
  • Legal & General Group first reported a position in TELA Bio in Q2 2020 and held it in 8 quarters.
  • Legal & General Group's TELA Bio position peaked at $19.6K in Q2 2023.
  • 68 funds tracked by Wall St. Rank held TELA Bio as of Q2 2024.

Based on Legal & General Group's 13F filing for Q2 2024, filed 14 Aug 2024.